Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Epogen

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Epogen was produced by Amgen.

AZ preps new roxadustat filings, though data foxes investors

AZ preps new roxadustat filings, though data foxes investors

Epoetin alfa is sold by Amgen as Epogen and Janssen as Procrit, but these brands were joined by Pfizer’s lower-cost biosimilar Retacrit last year.

China first market to approve AZ’s kidney drug roxadustat

China first market to approve AZ’s kidney drug roxadustat as Amgen’s Epogen (epoetin alfa) and Aranesp (darbepoetin alfa).

Pfizer gets FDA panel recommendation for biosimilar EPO

Pfizer gets FDA panel recommendation for biosimilar EPO Product could be the first direct competitor to Epogen and Procrit in the US. ... If the FDA follows its panel's advice – which it generally does – Pfizer will have a direct competitor to Amgen's Epogen and Johnson &Johnson Procrit blockbuster brands

Novartis gets FDA panel backing for biosimilar Enbrel

Novartis gets FDA panel backing for biosimilar Enbrel The company has several other biosimilars in clinical development, including copycat versions of Humira, Roche's MabThera/Rituxan (rituximab), Amgen's Epogen (epoetin alfa) and Neulasta (pegfilgrastim) and Johnson &Johnson's

Amgen biosimilar matches AbbVie's Humira in psoriasis trial

Amgen biosimilar matches AbbVie's Humira in psoriasis trial to its own drugs such as Neupogen (filgrastim) and Epogen (epoetin alfa) in Europe. .

1 2 3 4 5 6 7 8 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Empowering Strategic Performance Ltd

OUR GOAL: To help clients Metamorph™ Science into Action that changes healthcare to improve the lives of patients. Empowering Strategic...

Latest intelligence

Kulveer Singh
Surviving cancer: a new era for patients
Now more than ever, a shift in perspective is needed...
Crisis? No problem!
Issues planning & management for pharma spokespeople, by Andrew Smith...
Are patient recruitment and retention rates rising or falling?
First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....

Infographics